Is this you?
Request access for North Georgia Clinical Research using your company work email. Intera will contact you to verify and set up your account — nothing auto-publishes.
North Georgia Clinical Research
Unclaimed profileIndependent Site · Georgia · ~1 sites
Intera lens
ICP 5Lift (cardio sample) 1.00Recruit soph 0
Quality Scorecard (1–100)
Overall72Recruit49Ops80Sponsor81Ther80
Performance (observed)
Historical trials
280
Completed
174
Terminated/Withdrawn
29
Completion rate
86%
Active now
71
Phase 2
92
Phase 3
167
Realized enrollment
328,748
First study year
1995
Years active
31
Match confidence
high
Enrollment velocity (inf)
10,605
Therapeutic
Areas
Cardiometabolic (cardiology/endocrinology/hepatology/renal, per ClinicalTrials.gov)
Breadth (conditions)
554
States
Georgia
Recruitment (web observed)
Capability notes
4 active recruiting cardiometabolic trials (ClinicalTrials.gov)
Relationships
Sponsors
Pfizer; National Cancer Institute (NCI); AbbVie; SWOG Cancer Research Network; Eli Lilly and Company; Merck Sharp & Dohme LLC
CROs
ICON Clinical Research; IQVIA Biotech; IQVIA Pty Ltd; IQVIA Pvt. Ltd; Medpace, Inc.; PPD Development, LP
Owner / parent
Unknown
Capacity & people
Investigators
—
Coordinators
—
Tech & DCT
Builds tech
Unknown
Tech stack
Unknown
Recruiting visible
Y
Notes
Surfaced via ClinicalTrials.gov mining (not on curated lists). 4 active recruiting cardiometabolic trials across 1 location(s). Actively-recruiting independent site = warm Intera lead; website/leadership not yet verified.
Recommendation features (sample indication)
Ind fit 1.00Liftability 1.00Overall72
FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.